Retrospective observational study about the efficacy and safety of intrinsic antitachycardia pacing

Retrospective observational study about the efficacy and safety of intrinsic antitachycardia pacing - safe iATP

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000054126

Enrollment

128

Registered

2024-04-11

Start date

2024-04-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ventricular tachycardia(VT)

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: In patients underwent de novo ICD or Cardiac Resynchronization Therapy-Defibrillator (CRT-D) implantation in our hospital, we analyzed the patients who had appropriate ATP therapy for ventricular arrhythmia between August 2020 and August 2023.

Exclusion criteria

Exclusion criteria: Patients who were (1) implanted with CobaltTM devices but had the settings intentionally changed from the iATP to the cATP by the operator, (2) lacking detailed records of ATP episodes, or (3) performed manual ATP during ablation procedures or in the emergency department or other similar situations, were excluded.

Design outcomes

Primary

Measure	Time frame
The primary study endpoint was the ATP success rate for ventricular arrhythmia.	—

Countries

Japan

Contacts

Public ContactKoumei Onuki

Kokura Memorial Hospital Cardiology

umixsirakawa@gmail.com0935112000

Outcome results